Novo Nordisk Looks Beyond Weight Loss to Longevity and Aesthetics
Culture Index
Score Breakdown
Relevance
9/25
Freshness
23/25
Authority
25/20
Brand Signal
6/15
Depth
2/15
5-Axis Cultural Radar
Novo's blockbuster drugs could pull it into buzzier areas of healthcare, chief executive Mike Doustdar said, as the Ozempic maker seeks to lessen its reliance on obesity and diabetes.
